← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 12, 2017Last known activity
Dec 15, 2025
Timeline
2010s
- Jan 1, 2015
Taizhou Mabtech Pharmaceutical Co., Ltd.— Founded
Drugs by trial phase (11 distinct, 15 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (6 own, 0 via acquisition)
Phase 1 (4 own, 0 via acquisition)
Indications
Recent trials (15)
- NCT07254325Lead sponsorPhase 1Dec 15, 2025
- NCT06933069Lead sponsorPhase 1Jun 9, 2025
- NCT06398652Lead sponsorPhase 3Aug 27, 2024
- NCT06365879Lead sponsorPhase 3Jun 18, 2024
- NCT07246252Lead sponsorPhase 1Mar 28, 2024
- NCT06361355Lead sponsorPhase 1Nov 2, 2023
- NCT05906576Lead sponsorPhase 4Jul 31, 2023
- NCT05808673Lead sponsorPhase 1Jul 31, 2023
- NCT05734482Lead sponsorPhase 1Feb 15, 2023
- NCT05897008Lead sponsorPhase 1Feb 7, 2022
- NCT04778137Lead sponsorPhase 1Dec 1, 2020
- NCT04659369Lead sponsorPhase 1Sep 24, 2020
- NCT04779892Lead sponsorPhase 1Feb 1, 2020
- NCT04049409Lead sponsorPhase 1Jun 17, 2019
- NCT03206151Lead sponsorPhase 3Dec 12, 2017
Details
- Founded
- Taizhou, CN Jan 1, 2015
- Last known activity
- Dec 15, 2025